Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: J_F_Shepard who wrote (1211032)	3/20/2020 11:25:41 AM
From: SeachRE	3 Recommendations Recommended By J_F_Shepard pocotrader rdkflorida2 Respond to of 1578418

What all Trumptards are here for is to SPIN and spin again. There is NO PATRIOTISM...all that counts is their paychecks every month.

To: J_F_Shepard who wrote (1211032)	3/20/2020 11:31:47 AM
From: Sdgla	1 Recommendation Recommended By Winfastorlose Read Replies (1) \| Respond to of 1578418

Facts are what they are. The news source & messenger is irrelevant.

To: J_F_Shepard who wrote (1211032)	3/20/2020 6:54:56 PM
From: Winfastorlose	Read Replies (1) \| Respond to of 1578418

Brietbart is just the news source. Truth is still truth no matter what mouth speaks it. If you do not like them, then how about these people? Coronavirus : « La chloroquine, traitement contre le paludisme, est la meilleure réponse à l'épidémie » selon l'infectiologue Marseillais @DiderRaoult https://t.co/L7SAzDa4Em — Papearus (@PAPEARUS) February 29, 2020 UPDATE: Full peer reviewed study has been released by Didier Raoult MD, PhD https://t.co/DzFTv13wYn. After 6 days 100% of patients treated with HCQ + Azithromycin were virologically cured p-value <.0001https://t.co/vttAIWbPwJ — Gregory Rigano (@RiganoESQ) March 18, 2020 Recently completed French clinical trial. drive.google.com Read for the full report: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial Philippe Gautreta,b$ , Jean-Christophe Lagiera,c$ , Philippe Parolaa,b, Van Thuan Hoanga,b,d , Line Meddeba , Morgane Mailhea , Barbara Doudiera , Johan Courjone,f,g , Valérie Giordanengoh , Vera Esteves Vieiraa , Hervé Tissot Duponta,c , Stéphane Honoréi,j , Philippe Colsona,c, Eric Chabrièrea,c, Bernard La Scolaa,c, Jean-Marc Rolaina,c, Philippe Brouquia,c, Didier Raoulta,c* . a IHU-Méditerranée Infection, Marseille, France.